What Modified-Release Supplements Are (and Why You Can’t Crush Them)

Camden Medicals editorial · Last reviewed 27 Apr 2026 · Sources: NHS, NICE, BNF, EFSA, MHRA + primary literature

  • Cross-checked against
  • NHS
  • NICE
  • BNF
  • EFSA
  • FSA
  • MHRA
Topic
Supplements
Read time
5 min
Last reviewed
27 Apr 2026
Editorial tier
Supplements
On this page
  1. What “modified release” actually means
  2. The three sub-types you’ll see on a label
  3. How a modified-release tablet actually works
  4. Why the rule “never crush, split, or chew” matters
  5. When modified release is the right choice
  6. NMN — a current candidate for modified release
  7. How to recognise a modified-release product on the label
  8. The bottom line
  9. Related Camden Medicals reading
  10. Sources and further reading

Quick answer: “Modified release” is an umbrella term for any tablet or capsule designed to release its active ingredient at a controlled rate rather than all at once. It includes delayed release (e.g. an enteric coating that bypasses the stomach), extended release (the active is dispersed over several hours), and sustained release (a sub-type of extended release). Always swallow modified-release tablets whole — never crush, split, or chew them, because that defeats the release mechanism.

What “modified release” actually means

An ordinary, “immediate-release” tablet dissolves in the stomach within minutes and releases its full dose of the active ingredient in one go. The bloodstream sees a quick rise in concentration, peaks within an hour or two, and then drops as the body clears the substance. For many medicines and supplements this is exactly what is wanted.

For some active ingredients, though, an instant peak followed by a steep drop is a problem — either because the body cannot use that much in one go, because the ingredient is uncomfortable to take in a single large dose, or because a steady, lower concentration over hours produces a better result. Modified-release formulations are designed for those cases.

The three sub-types you’ll see on a label

  • Delayed release — the tablet is coated so it doesn’t release in the stomach. The most common example is an “enteric coating” that resists stomach acid and only dissolves in the more alkaline small intestine. Used when the active ingredient irritates the stomach lining or is destroyed by stomach acid.
  • Extended release (sometimes labelled “sustained release”, “prolonged release”, or “controlled release” — the regulators treat these as broadly synonymous) — the active is embedded in a slowly-eroding matrix or coated in a way that lets it diffuse out gradually. The blood concentration rises more slowly, plateaus for longer, and falls more gently.
  • Pulsatile release — designed to release a dose at a specific later time (rare in supplements; more common in chronotherapy of certain medicines).

The umbrella term modified release covers all of these. The European Medicines Agency, the US FDA, and the British Pharmacopoeia all use this terminology in similar ways.

How a modified-release tablet actually works

Most modified-release tablets in supplements use a hydrophilic matrix: the active ingredient is mixed into a polymer that swells when it meets water in the gut. The polymer forms a gel layer around the tablet, and the active ingredient diffuses through that gel layer at a controlled rate. As the outer gel erodes, fresh polymer below is exposed and the process continues until the tablet is fully consumed.

The most common matrix material is hypromellose (HPMC) — a chemically modified plant cellulose used in pharmaceutical manufacturing for over half a century. HPMC has been the dominant hydrophilic-matrix material for sustained-release oral solid dosage forms for decades, evaluated for safety by the European Food Safety Authority (EFSA) at the levels used in food and supplements.

For delayed-release products, an enteric coating made of methacrylic acid copolymers, hydroxypropyl methylcellulose phthalate, or similar polymers wraps the tablet. The coating is stable at the low pH of the stomach but dissolves above approximately pH 5.5 in the small intestine.

Why the rule “never crush, split, or chew” matters

Crushing or splitting a modified-release tablet defeats the release mechanism in three ways:

  • The intact polymer matrix is needed to form the gel layer. Once you fragment it, the active ingredient is released much faster.
  • You can deliver an unintended large dose all at once. For some actives this means side effects or, in the case of medicines with narrow safety margins, real harm.
  • For an enteric-coated tablet, breaking the coating exposes the active to stomach acid (which may destroy it) or the stomach lining to the active (which may irritate it).

If you have trouble swallowing tablets and your prescribed medicine is modified-release, talk to your pharmacist before crushing — there may be a liquid or quick-dissolve formulation available. For supplements, the same rule applies: if the label says “modified release”, “extended release”, “sustained release”, or “delayed release”, swallow whole.

When modified release is the right choice

For most everyday vitamins and minerals, immediate-release tablets are perfectly appropriate. Modified release is most useful in three situations:

  • Active ingredients that the body uses in pulses — niacin (vitamin B3) is the classic example: a sustained-release form reduces the “flush” reaction that high doses of immediate-release niacin cause.
  • Active ingredients that have a short half-life — without sustained release, they would need to be taken several times a day to keep blood levels steady.
  • Active ingredients that irritate the stomach or are destroyed by stomach acid — enteric coating bypasses the stomach.

NMN — a current candidate for modified release

NMN (β-nicotinamide mononucleotide) is one of the supplement ingredients where the modified-release format is being evaluated. NMN has a very short half-life in the body, and the most-cited research uses dosing patterns that an immediate-release tablet can’t easily reproduce in a single daily dose. A modified-release HPMC matrix can spread the dose over hours and may smooth that profile out.

That said, the regulatory status of NMN as a food supplement in Great Britain is currently restricted — see the NMN ingredient page for the current FSA Novel Foods position before considering any NMN supplement.

How to recognise a modified-release product on the label

  • The words modified release, extended release, sustained release, prolonged release, controlled release, or delayed release on the front of the pack or in the product name.
  • An abbreviation like MR, XL, SR, PR, CR, ER, or XR after the product name.
  • “Enteric coated” or “gastro-resistant” — these are types of delayed release.
  • An instruction in the patient information leaflet to “swallow whole” and “do not crush or chew”.

If none of those appear, the product is almost certainly an ordinary immediate-release formulation.

The bottom line

Modified-release supplements are a real and useful pharmaceutical tool, not a marketing label — they smooth out blood-level peaks, protect stomach-irritating actives, and reduce the number of doses needed each day. They are not, in themselves, a quality marker — most everyday vitamins and minerals don’t need them. The safety rule is consistent across all sub-types: swallow whole, never crush or chew. And if you’re not sure whether a tablet is modified-release, the patient information leaflet — or your pharmacist — is the right place to check.

Sources and further reading

  1. EMA — Guideline on quality of oral modified-release products (EMA/CHMP/QWP/428693/2013)
  2. FDA — Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations (1997)
  3. EFSA — Re-evaluation of celluloses including hypromellose (E464), 2018 (open access mirror at PMC)
  4. Royal Pharmaceutical Society — Pharmaceutical issues when crushing, opening or splitting oral dosage forms

Camden Medicals editorial. Information, not medical advice — talk to your pharmacist or GP about any supplement before starting, especially if you take prescribed medicines, are pregnant or breastfeeding, or have an existing condition. Suspected side effects can be reported to the MHRA via the Yellow Card scheme.